About this event
Join us for this unique three-part webinar series, Precision Oncology ONLINE, as we delve into how detecting rare sequences can shape our understanding and approach to treating cancer. We will also deep-dive into examples and lessons learned from delivering precision oncology with examples in both solid-tumours and haematological cancers.
27th September at 3pm BST/ 4pm CET/ 10am EST
Advances in digital PCR technologies have enabled us to detect and measure cancer alterations at unparalleled resolution, finding rare alleles or sequences which could unlock the power to transform patient care. Detecting and monitoring cancer biomarkers can transform patient care, so how can we best leverage these technologies to deliver on precision oncology?
In this webinar, we will deep-dive into the technology that can give unparalleled resolution into the cancer genome, and how this is being applied to deliver precision oncology in practice.
Previous webinars in the series:
Tuesday 13th September at 3pm BST/ 4pm CET/ 10am EST
Since the discovery of the EGFR mutation that sensitised non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors, NSCLC has been a great example of precision oncology in solid tumours.
However, since the emergence of resistance to EGFR tyrosine kinase inhibitors, there is a medical need to improve our understanding of cancer evolution and develop more robust diagnostic tools and treatment options in NSCLC cancer patients.
In this webinar, we focus on current research on the status and future development of precision medicine in NSCLC.
20th September at 3pm BST/ 4pm CET/ 10am EST
In this webinar, we will evaluate the strengths of molecular profiling in delivering precision medicine for blood cancers.
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.
Share this event